Researchers conducted a study to assess whether nonpharmaceutical interventions effectively prevent COVID-19 transmission following high-risk exposures.
Using data from the COVAX physician-reported registry, researchers studied the safety of SARS-CoV-2 vaccines in patients with inflammatory/autoimmune rheumatic and musculoskeletal diseases.
Cutaneous manifestations after COVID-19 vaccination are recorded and reported by researchers.
Patients aged younger than 18 years with diagnosed COVID-19 have an increased risk for newly diagnosed diabetes >30 days after acute infection.
Shortages of both supplies and workers are wreaking havoc on the efforts of COVID-19 at-home test makers to deliver enough of the tests to Americans.
The risk for hospitalization for COVID-19 among older Americans is far higher for those who are unvaccinated than for those who are fully vaccinated and have had a booster shot.
A delay of five or more hours to admission from the emergency department is associated with increased all-cause 30-day mortality.
Researchers sought to assess outcomes among patients in South Africa who were hospitalized with COVID-19 infection during the Omicron wave compared with previous waves.
Investigators assessed virological, biochemical, and clinical outcomes following cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B.
Gilead has “executed seizures at 17 locations in 9 states, seizing thousands of bottles of Gilead-labeled medication with counterfeit supply chain documentation.”
Will there be a post-pandemic re-emergence of RSV? A simulation model shows clinicians and hospitals need to be prepared for atypical RSV outbreaks.
Patients with even nonsevere COVID-19 seek health care frequently within 30 days of diagnosis, according to a study published online.
Insurers could prevent substantial waste by restricting prescription coverage for inappropriate use of ivermectin for COVID-19.
The inclusion of a certified wound and skin care nurse on a multiprofessional prone-positioning team significantly reduces the odds of pressure injuries developing in patients hospitalized with severe COVID-19.
A fourth dose of an mRNA-based anti-SARS-CoV-2 vaccine may increase antispike immunoglobulin (Ig)G titers in kidney transplant recipients.
Researchers conducted a study to determine the relationship between immune dysfunction and the risk for COVID-19 breakthrough infection following vaccination.
Researchers conducted a study to determine whether surgical intervention for weight loss decreases the risk for severe COVID-19.
During a season predominated by 2 vaccine-mismatched viruses, vaccination was estimated to reduce the risk of life-threatening influenza illness by 75%.
The randomized, double-blind, placebo-controlled study included a total of 380 patients aged 6 to 71 months with nonsevere CAP.
Numerous COVID-19 restrictions will be dropped in England because government experts believe the omicron variant “has now peaked nationally.”